SEC to reconvene on Jan 1 to consider emergency use authorisation for Covid-19 Vaccines

​​​​​​The subject expert committee on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) on December 9 had sought additional safety and efficacy data for Covid-19 vaccines of SII and Bharat Biotech after deliberating upon their applications.